Primary Site >> Stomach Cancer
Gene >> EIF3A
| 1. | |||||||||||
| Journal: | J Cancer Res Clin Oncol. 1992;118(6):474-9. | ||||||||||
| Title: | Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma. | ||||||||||
| Author: | Jaehne, J|Urmacher, C|Thaler, H T|Friedlander-Klar, H|Cordon-Cardo, C|Meyer, H J | ||||||||||
| PMID: | 1352299 | ||||||||||
| 2. | |||||||||||
| Journal: | Chirurg. 1994 Apr;65(4):307-11. | ||||||||||
| Title: | [Molecular biology and immunohistochemical studies of Her2/neu oncogene in stomach cancer]. | ||||||||||
| Author: | Jahne, J|Urmacher, C|Albino, A|Meyer, H J|Pichlmayr, R | ||||||||||
| PMID: | 7912666 | ||||||||||
| 3. | |||||||||||
| Journal: | J Med Chem. 1995 Sep 15;38(19):3806-12. | ||||||||||
| Title: | Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives. | ||||||||||
| Author: | Schnur, R C|Corman, M L|Gallaschun, R J|Cooper, B A|Dee, M F|Doty, J L|Muzzi, M L|Moyer, J D|DiOrio, C I|Barbacci, E G | ||||||||||
| PMID: | 7562911 | ||||||||||
| 4. | |||||||||||
| Journal: | J Med Chem. 1995 Sep 15;38(19):3813-20. | ||||||||||
| Title: | erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships. | ||||||||||
| Author: | Schnur, R C|Corman, M L|Gallaschun, R J|Cooper, B A|Dee, M F|Doty, J L|Muzzi, M L|DiOrio, C I|Barbacci, E G|Miller, P E | ||||||||||
| PMID: | 7562912 | ||||||||||
| 5. | |||||||||||
| Journal: | Zhonghua Zhong Liu Za Zhi. 1995 Sep;17(5):336-9. | ||||||||||
| Title: | [Expression of ras and erbB2 in benign and malignant lesions of the stomach]. | ||||||||||
| Author: | Zhao, A|Li, J|Lu, Y | ||||||||||
| PMID: | 8697969 | ||||||||||
| 6. | |||||||||||
| Journal: | Biol Pharm Bull. 1995 Sep;18(9):1279-82. | ||||||||||
| Title: | Immunoselective cell growth inhibition by antibody-adriamycin conjugates targeting c-erbB-2 product on human cancer cells. | ||||||||||
| Author: | Suzuki, S|Tanaka, M|Masuko, T|Hashimoto, Y | ||||||||||
| PMID: | 8845823 | ||||||||||
| 7. | |||||||||||
| Journal: | World J Gastroenterol. 1997 Jun 15;3(2):122. | ||||||||||
| Title: | Expression of the c-erbB-2 proto-oncogene product in gastric carcinoma and precancerous lesions. | ||||||||||
| Author: | Mi, J Q|Yang, S Q|Shen, M C | ||||||||||
| PMID: | 27041970 | ||||||||||
| 8. | |||||||||||
| Journal: | J Clin Oncol. 2000 Jun;18(11):2201-9. | ||||||||||
| Title: | c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. | ||||||||||
| Author: | Allgayer, H|Babic, R|Gruetzner, K U|Tarabichi, A|Schildberg, F W|Heiss, M M | ||||||||||
| PMID: | 10829039 | ||||||||||
| 9. | |||||||||||
| Journal: | J Cell Biochem. 2001;80(4):483-90. | ||||||||||
| Title: | Molecular interaction between human tumor marker protein p150, the largest subunit of eIF3, and intermediate filament protein K7. | ||||||||||
| Author: | Lin, L|Holbro, T|Alonso, G|Gerosa, D|Burger, M M | ||||||||||
| PMID: | 11169732 | ||||||||||
| 10. | |||||||||||
| Journal: | Int J Cancer. 2002 Apr 20;98(6):833-7. | ||||||||||
| Title: | Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay. | ||||||||||
| Author: | Takehana, Takuo|Kunitomo, Kazuyoshi|Kono, Koji|Kitahara, Fumiaki|Iizuka, Hidehiko|Matsumoto, Yoshiro|Fujino, Masayuki A|Ooi, Akishi | ||||||||||
| PMID: | 11948459 | ||||||||||
| 11. | |||||||||||
| Journal: | World J Gastroenterol. 2002 Dec;8(6):1005-8. | ||||||||||
| Title: | Mast cell density and the context of clinicopathological parameters and expression of p185, estrogen receptor, and proliferating cell nuclear antigen in gastric carcinoma. | ||||||||||
| Author: | Jiang, Ying-An|Zhang, You-Yuan|Luo, He-Sheng|Xing, Shou-Fu | ||||||||||
| PMID: | 12439914 | ||||||||||
| 12. | |||||||||||
| Journal: | Cancer Res Treat. 2003 Apr;35(2):109-16. | ||||||||||
| Title: | The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines. | ||||||||||
| Author: | Im, Seock Ah|Lee, Kyung Eun|Nam, Eunmi|Nam, Seung Hyun|Kim, Do Yeun|Seong, Chu Myong|Park, Hae Young|Han, Woon Sup|Seoh, Ju Young|Lee, Soon Nam | ||||||||||
| PMID: | 26680923 | ||||||||||
| 13. | |||||||||||
| Journal: | Tumori. 2005 Nov-Dec;91(6):513-21. | ||||||||||
| Title: | Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas. | ||||||||||
| Author: | Im, Seock-Ah|Lee, Kyung Eun|Nam, Eunmi|Kim, Do Yeun|Lee, Joo-Ho|Han, Ho-Seong|Seoh, Ju-Young|Park, Hae-Young|Cho, Min-Sun|Han, Woon Sup|Lee, Soon Nam | ||||||||||
| PMID: | 16457151 | ||||||||||
| 14. | |||||||||||
| Journal: | Med Princ Pract. 2016;25(5):461-5. | ||||||||||
| Title: | Impact of a Eukaryotic Translation Initiation Factor 3a Polymorphism on Susceptibility to Gastric Cancer. | ||||||||||
| Author: | Liu, Kuijie|Lei, Zhendong|Yao, Hongliang|Lei, Sanlin|Zhao, Hua | ||||||||||
| PMID: | 27333287 | ||||||||||
| 15. | |||||||||||
| Journal: | Cancer Manag Res. 2017 Oct 25;9:539-544. | ||||||||||
| Title: | High expression of eIF3d is associated with poor prognosis in patients with gastric cancer. | ||||||||||
| Author: | He, Jiaqi|Wang, Xuefei|Cai, Jianhua|Wang, Wei|Qin, Xinyu | ||||||||||
| PMID: | 29123423 | ||||||||||